Physician profile
Tracy Kwan
NPI 1144973207
$747.57
in general payments reported to CMS, 2019-2025
16 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $106 · 2023: $188 · 2024: $163 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $641.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $95.44 | 2023-2025 | |
| Novo Nordisk INC | $86.88 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Coopersurgical, INC. | $78.38 | 2025 | Paragard T 380a |
| Astellas Pharma US INC | $71.88 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $67.25 | 2023-2025 | Cologuard Collection Kit |
| Myriad Women'S Health, INC. | $67.06 | 2023 | Myrisk |
| Hologic Sales and Service, LLC | $48.76 | 2025 | Aptima |
| Lilly USA, LLC | $43.91 | 2022 | |
| Evofem Biosciences, INC. | $40.44 | 2023-2025 | Phexxi, Solosec, Phexx |
| Organon LLC | $37.65 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $24.76 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.81 | 2022 | |
| Sumitomo Pharma America, INC. | $19.15 | 2024 | Myfembree |
| Millicent US INC | $16.32 | 2024 | Intrarosa |
| Medtronic, INC. | $15.69 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $12.19 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Kwan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.